Top Story

The state of dry eye care, part 2

The state of dry eye care, part 2
Ocular Surgery News U.S. Edition, July 25, 2017
Darrell E. White, MD

As we head into the summer months, I thought it would be helpful to take the pulse of our dry eye world and report on the state of the state, if you will. In part 1 I reviewed how we are diagnosing dry eye in our clinics — and learned that the news cycle does not respect the editorial/creative process when RPS sold InflammaDry while my piece was in turnaround. Let us now examine the state of dry eye disease treatment.

As a group, doctors who treat DED have become much more sophisticated in how they approach care. An ophthalmologist or optometrist makes an effort to confirm that it is, indeed, DED that is producing the majority of a patient’s symptoms. Once this is accomplished, we then determine if the primary type of the dry eye is aqueous deficient or evaporative. From this starting point there are, at the moment, two major treatment pathways: address the health of meibomian glands and address the presence of inflammation.

Uveitis can complicate cataract surgery and limit vision gains

Ocular Surgery News U.S. Edition, July 25, 2017
Postoperative vision gains in eyes with uveitis that undergo cataract surgery are about a line less compared with healthy eyes that undergo the same procedure, according…

Sustained-release therapies remove patient factor from glaucoma treatment

Ocular Surgery News U.S. Edition, July 25, 2017
Sustained delivery devices that take glaucoma therapy out of patients’ hands may be the answer to the many issues related to adherence, with significant benefits…
Grand Rounds at the New England Eye Center

Man presents with blurry vision, flashes, floaters and redness

Ocular Surgery News U.S. Edition, July 25, 2017
Deborah Witkin, MD; Andre Witkin, MD
A 53-year-old Caucasian man presented with a 3-week history of worsening blurry vision of the left eye associated with flashes, floaters and redness. He also complained…

Ophthalmologists explore scientific and personal aspects of near-death experience

Ocular Surgery News U.S. Edition, July 25, 2017
John C. Hagan III, MD, FACS, FAAO; Jean R. Hausheer, MD, FACS
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the…
More News Headlines »
Clinical Science

Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice

Ophthalmic Surgery, Lasers and Imaging Retina, June 2017, Volume 48 Issue 6
To determine outcomes of intravitreal ranibizumab (IVR) (Lucentis; Genentech, South San Francisco, CA) versus…
More »

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

This activity is supported by educational grants from AbbVie, Inc.

Uveitis is one of the leading causes of preventable blindness worldwide with a prevalence in the US of about 38 cases…
More »
Resource Centers
Meeting News

VIDEO: Mitro updates Roclatan studies, Aerie financing

June 26, 2017
More »